Latest Alector News & Updates

See the latest news and media coverage for Alector. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Alector

Biopharmaceutical company developing therapies for neurodegenerative diseases

alector.com
Headquarters
South San Francisco, United States
Founded year
2013
Company type
Public company
Number of employees
120–200
Industry
Pharmaceuticals

Last updated

Latest news about Alector

In short: Alector reported $124.6 million in Q3 net income, licensed AL050 to Genentech, and raised $75 million.

Company announcements

Alector

Alector reports Q2 2026 financial results and pipeline updates

Cash reserves stand at $172.8 million, extending runway through 2027. The company also highlighted progress in its ABC platform programs including AL137 for Alzheimer's disease.

Unlock all announcements with a

Media coverage

BioSpace

GSK-partnered Alector hit with third neuro failure as Alzheimer’s asset disappoints - BioSpace

Over the last two years, Alector has suffered three setbacks for its neurodegenerative disease pipeline, often forcing the company to downsize.

Unlock all articles with a

Never miss news about Alector

Track Alector and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.